Immunodeficiencies

• CLINICAL_TRIALS trial_result · 2026-07-21
  Clinical Trial Results: Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders [Phase 2]

  Phase 2 trial evaluating a Reduced Intensity Conditioning regimen for patients with non-malignant disorders; results completed and posted in…

• CLINICAL_TRIALS trial_result · 2024-01-18
  Clinical Trial Update: CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell Depletion [Phase 2]

  A Phase 2 trial evaluating CHP 834 for unrelated and partially matched related donor peripheral stem cell transplantation with T and B cell …

• CLINICAL_TRIALS trial_result · 2019-03-27
  Clinical Trial Update: Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders [Phase 1, Phase 2]

  Phase 1/2 clinical trial evaluating double cord blood transplant for malignant and non-malignant disorders; study terminated with results po…

• CLINICAL_TRIALS trial_result · 2018-08-21
  Clinical Trial Update: CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant [Phase 2]

  Phase 2 clinical trial update on CD34+ selection for partially matched family or matched unrelated adult donor transplants in leukemia and l…

• CLINICAL_TRIALS trial_result · 2018-04-11
  Clinical Trial Update: Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases [Phase 2]

  Phase 2 trial evaluating reduced intensity conditioning using CD3+/CD19+ depletion for non-malignant transplantable diseases completed with …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2015-04-15
  Clinical Trial Update: Unrelated Donor Transplant for Malignant and Non-Malignant Disorders [Phase 2]

  Phase 2 trial of unrelated donor transplantation for malignant and non-malignant hematologic disorders; the study status is terminated.